Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Morgan Stanley
MS
$336B
| $21.8M | 0.01% |
680,247
-3,626,664
| -84% | -$108M |
|
|
MMP
952
CALL
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $21.8M | 0.01% |
307,900
-186,400
| -38% | -$13.3M |
|
953
PUT
Lumen
LUMN
$5.85B
| $21.8M | 0.01% |
793,000
+394,500
| +99% | +$11.5M |
|
954
PUT
Lam Research
LRCX
$388B
| $21.7M | 0.01% |
2,292,000
+1,607,000
| +235% | +$14.6M |
|
955
PUT
Tapestry
TPR
$26.4B
| $21.7M | 0.01% |
593,000
+45,100
| +8% | +$1.79M |
|
956
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.84B
| $21.7M | 0.01% |
806,624
+238,316
| +42% | +$6.3M |
|
957
PUT
Stryker
SYK
$126B
| $21.6M | 0.01% |
185,400
+2,200
| +1% | +$256K |
|
958
PUT
BlackBerry
BB
$4.48B
| $21.6M | 0.01% |
2,701,200
-1,157,700
| -30% | -$8.69M |
|
959
PUT
PNC Financial Services
PNC
$97.2B
| $21.5M | 0.01% |
239,100
+62,700
| +36% | +$5.38M |
|
960
CALL
NOV
NOV
$7.04B
| $21.5M | 0.01% |
586,100
+13,400
| +2% | +$450K |
|
961
CALL
Keurig Dr Pepper
KDP
$44.2B
| $21.4M | 0.01% |
234,900
+141,900
| +153% | +$13.4M |
|
962
CALL
Genesis Energy
GEL
$1.97B
| $21.4M | 0.01% |
563,700
-187,100
| -25% | -$6.86M |
|
963
PUT
Fluor
FLR
$6.86B
| $21.4M | 0.01% |
416,900
-77,100
| -16% | -$3.98M |
|
964
CALL
Royal Caribbean
RCL
$78.4B
| $21.4M | 0.01% |
285,400
-265,700
| -48% | -$18.7M |
|
|
965
CALL
Tapestry
TPR
$26.4B
| $21.4M | 0.01% |
584,600
-376,000
| -39% | -$14.9M |
|
966
Alcoa
AA
$13B
| $21.3M | 0.01% |
874,795
-335,343
| -28% | -$8.18M |
|
967
PUT
CarMax
KMX
$8.91B
| $21.3M | 0.01% |
398,400
-12,300
| -3% | -$697K |
|
968
CALL
Vipshop
VIPS
$6.88B
| $21.2M | 0.01% |
1,445,500
+243,100
| +20% | +$3.42M |
|
|
MNDT
969
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $21.2M | 0.01% |
1,437,500
+245,400
| +21% | +$3.77M |
|
970
CALL
Sanofi
SNY
$109B
| $21.2M | 0.01% |
554,400
+264,700
| +91% | +$10.6M |
|
971
CALL
Alnylam Pharmaceuticals
ALNY
$31.6B
| $21.1M | 0.01% |
311,000
-9,500
| -3% | -$670K |
|
|
ASRT
972
CALL
DELISTED
Assertio
ASRT
| $21.1M | 0.01% |
14,040
+2,810
| +25% | +$3.53M |
|
|
973
PUT
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.84B
| $21M | 0.01% |
783,200
-249,200
| -24% | -$6.59M |
|
|
TSRO
974
CALL
DELISTED
TESARO, Inc.
TSRO
| $21M | 0.01% |
209,800
+107,200
| +104% | +$10M |
|
|
WNR
975
CALL
DELISTED
Western Refining Inc
WNR
| $21M | 0.01% |
794,600
+457,500
| +136% | +$10.8M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.57B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,275 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.